1.1 A bill for an act
1.2 relating to health; modifying insulin manufacturer registration fee provisions;
1.3 amending Minnesota Statutes 2024, section 151.741, subdivision 2.
1.4BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.5 Section 1. Minnesota Statutes 2024, section 151.741, subdivision 2, is amended to read:
1.6 Subd. 2.Assessment of registration fee.(a) The board shall assess each manufacturer
1.7an annual registration fee of $100,000, except as provided in paragraph (b). The board shall
1.8notify each manufacturer of this requirement beginning November 1, 2024, and each
1.9November 1 thereafter. The commissioner of health shall provide technical assistance to
1.10the board using available data sources, including but not limited to data collected under
1.11section 62U.04.
1.12 (b) A manufacturer may request an exemption from the annual registration fee. The
1.13board shall exempt a manufacturer from the annual registration fee if the manufacturer can
1.14demonstrate to the board, in the form and manner specified by the board, that gross revenue
1.15total wholesale acquisition cost from sales of dispensing claims within or into Minnesota
1.16for prescription insulin produced by that manufacturer and sold or delivered within or into
1.17Minnesota was less than five percent of the total gross revenue wholesale acquisition cost
1.18from sales of prescription insulin produced by all manufacturers and sold or delivered within
1.19or into Minnesota dispensing claims of prescription insulin products by all manufacturers
1.20within or into Minnesota in the previous calendar year.
1Section 1.
REVISOR AGW/DG 25-0443703/07/25
State of Minnesota
This Document can be made available
in alternative formats upon request
HOUSE OF REPRESENTATIVES
H. F. No. 2275
NINETY-FOURTH SESSION
Authored by Howard03/13/2025
The bill was read for the first time and referred to the Committee on Health Finance and Policy